RecensMedical, Inc. (KOSDAQ:394420)
South Korea flag South Korea · Delayed Price · Currency is KRW
17,250
-900 (-4.96%)
At close: Jun 12, 2026

RecensMedical Statistics

Total Valuation

RecensMedical has a market cap or net worth of KRW 187.17 billion. The enterprise value is 175.15 billion.

Market Cap187.17B
Enterprise Value 175.15B

Important Dates

The next estimated earnings date is Monday, June 29, 2026.

Earnings Date Jun 29, 2026
Ex-Dividend Date n/a

Share Statistics

RecensMedical has 10.85 million shares outstanding. The number of shares has increased by 143.81% in one year.

Current Share Class 10.85M
Shares Outstanding 10.85M
Shares Change (YoY) +143.81%
Shares Change (QoQ) -1.05%
Owned by Insiders (%) 20.43%
Owned by Institutions (%) 9.05%
Float 6.39M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 24.64
PB Ratio 8.89
P/TBV Ratio 8.97
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 23.06
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.70, with a Debt / Equity ratio of 0.29.

Current Ratio 4.70
Quick Ratio 3.91
Debt / Equity 0.29
Debt / EBITDA n/a
Debt / FCF -0.56
Interest Coverage -8.82

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -42.17%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 31.64
Average Volume (20 Days) 305,914

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RecensMedical had revenue of KRW 7.60 billion and -17.38 billion in losses. Loss per share was -2,148.78.

Revenue7.60B
Gross Profit 4.29B
Operating Income -10.64B
Pretax Income -17.38B
Net Income -17.38B
EBITDA -10.08B
EBIT -10.64B
Loss Per Share -2,148.78
Full Income Statement

Balance Sheet

The company has 18.19 billion in cash and 6.18 billion in debt, with a net cash position of 12.01 billion or 1,107.14 per share.

Cash & Cash Equivalents 18.19B
Total Debt 6.18B
Net Cash 12.01B
Net Cash Per Share 1,107.14
Equity (Book Value) 21.06B
Book Value Per Share 2,257.95
Working Capital 20.94B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.10 billion and capital expenditures -848.18 million, giving a free cash flow of -10.95 billion.

Operating Cash Flow -10.10B
Capital Expenditures -848.18M
Depreciation & Amortization 556.14M
Net Borrowing 4.65B
Free Cash Flow -10.95B
FCF Per Share -1,008.91
Full Cash Flow Statement

Margins

Gross margin is 56.48%, with operating and profit margins of -140.03% and -228.74%.

Gross Margin 56.48%
Operating Margin -140.03%
Pretax Margin -228.74%
Profit Margin -228.74%
EBITDA Margin -132.71%
EBIT Margin -140.03%
FCF Margin n/a

Dividends & Yields

RecensMedical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -143.81%
Shareholder Yield -143.81%
Earnings Yield -9.28%
FCF Yield -5.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RecensMedical has an Altman Z-Score of 6.77 and a Piotroski F-Score of 3.

Altman Z-Score 6.77
Piotroski F-Score 3